Get the Stockscreener App
17.81
0.29%
0.0427
Entrada Therapeutics Inc stock is traded at $17.81, with a volume of 80,534.
It is up +0.29% in the last 24 hours and up +4.41% over the past month.
Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.
See More
Previous Close:
$17.77
Open:
$18.05
24h Volume:
80,534
Relative Volume:
0.63
Market Cap:
$666.80M
Revenue:
$239.40M
Net Income/Loss:
$104.44M
P/E Ratio:
-6.9041
EPS:
-2.58
Net Cash Flow:
$-18.50M
1W Performance:
+3.14%
1M Performance:
+4.41%
6M Performance:
+35.43%
1Y Performance:
+7.04%
1-Day Range:
$17.25
$18.06
1-Week Range:
$17.04
$18.10
52-Week Range:
$10.75
$18.17
Entrada Therapeutics Inc Stock (TRDA) Company Profile
Name
Entrada Therapeutics Inc
Sector
Industry
Phone
857-305-1825
Address
ONE DESIGN CENTER PLACE, BOSTON
Entrada Therapeutics Inc Stock (TRDA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-05-24 | Initiated | Oppenheimer | Outperform |
| Apr-03-23 | Initiated | H.C. Wainwright | Buy |
Entrada Therapeutics Inc Stock (TRDA) Latest News
Entrada Therapeutics : Corporate Presentation - Marketscreener.com
Entrada Therapeutics Reports Third Quarter 2024 Financial Results - The Manila Times
Here's Why Momentum in Entrada Therapeutics (TRDA) Should Keep going - MSN
Entrada Therapeutics, Inc. (NASDAQ:TRDA) Short Interest Down 19.1% in October - MarketBeat
Short Interest in Entrada Therapeutics, Inc. (NASDAQ:TRDA) Declines By 19.1% - Defense World
Here's What Could Help Entrada Therapeutics (TRDA) Maintain Its Recent Price Strength - MSN
Entrada Therapeutics president sells $10,800 in stock By Investing.com - Investing.com Australia
Natarajan Sethuraman Sells 600 Shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA) Stock - MarketBeat
Insider Sale at Entrada Therapeutics Inc (TRDA) by President of Research & Development - GuruFocus.com
There Is A Reason Entrada Therapeutics, Inc.'s (NASDAQ:TRDA) Price Is Undemanding - Simply Wall St
Oppenheimer Initiates Coverage of Entrada Therapeutics (TRDA) with Outperform Recommendation - MSN
(TRDA) Trading Report - Stock Traders Daily
The Manufacturers Life Insurance Company Purchases 2,146 Shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA) - Defense World
Renaissance Technologies LLC Invests $636,000 in Entrada Therapeutics, Inc. (NASDAQ:TRDA) - MarketBeat
Entrada Therapeutics advances Duchenne treatment trials - Investing.com
Entrada Therapeutics advances Duchenne treatment trials By Investing.com - Investing.com UK
Entrada Therapeutics Presents New Data Supporting its Expanding Duchenne Franchise at the 29th Annual Congress of the World Muscle Society - The Manila Times
(TRDA) Trading Advice - Stock Traders Daily
Morguard Un (MRT-UN-T) QuotePress Release - The Globe and Mail
Pompe Disease Pipeline Update 2024: FDA Approvals, Therapeutic Advancements, and Market Dynamics, MOA, ROA by DelveInsight | M6P Therapeutics, Entrada Therapeutics, Maze Therapeutics, Astellas - The Globe and Mail
Entrada Therapeutics COO sells shares worth over $13,000 - Investing.com India
Entrada Therapeutics COO sells shares worth over $13,000 By Investing.com - Investing.com Australia
Insider Sale: President & COO Nathan Dowden Sells Shares of Entr - GuruFocus.com
Entrada Therapeutics (NASDAQ:TRDA) Trading 4.8% Higher - MarketBeat
U.S. Gold Corp (USAU-Q) QuotePress Release - The Globe and Mail
Entrada Therapeutics Promotes Natarajan Sethuraman, PhD, to President of Research and Development - Markets Insider
Entrada Therapeutics appoints new President of R&D - Investing.com
TherapeuticsMD Inc. stock underperforms Monday when compared to competitors - MarketWatch
30 Shares in Mettler-Toledo International Inc. (NYSE:MTD) Acquired by Itau Unibanco Holding S.A. - Defense World
STERIS plc (NYSE:STE) Shares Sold by XTX Topco Ltd - Defense World
Mettler-Toledo International's (NYSE:MTD) investors will be pleased with their decent 100% return over the last five years - Simply Wall St
Mutual of America Capital Management LLC Cuts Position in Mettler-Toledo International Inc. (NYSE:MTD) - Defense World
Lavaca Capital LLC Acquires New Position in Mettler-Toledo International Inc. (NYSE:MTD) - Defense World
Mettler-Toledo International Inc. (NYSE:MTD) Shares Purchased by Epoch Investment Partners Inc. - Defense World
Seven Eight Capital LP Has $607,000 Stake in Mettler-Toledo International Inc. (NYSE:MTD) - Defense World
Mettler-Toledo International Inc. (NYSE:MTD) Holdings Lowered by Ensign Peak Advisors Inc - Defense World
Entrada Therapeutics (NASDAQ:TRDA) Shares Up 6.7% - Defense World
GM Advisory Group LLC Takes $214,000 Position in Mettler-Toledo International Inc. (NYSE:MTD) - Defense World
Mettler-Toledo International Inc. (NYSE:MTD) Shares Acquired by Beddow Capital Management Inc. - Defense World
Dimensional Fund Advisors LP Cuts Stake in Mettler-Toledo International Inc. (NYSE:MTD) - Defense World
Mettler-Toledo International Inc. (NYSE:MTD) Shares Bought by Axxcess Wealth Management LLC - Defense World
Entrada Therapeutics (NASDAQ:TRDA) Stock Price Up 6.7% - MarketBeat
Tredje AP fonden Trims Stock Position in Mettler-Toledo International Inc. (NYSE:MTD) - Defense World
Mettler-Toledo International Inc. (NYSE:MTD) Stake Reduced by Meiji Yasuda Asset Management Co Ltd. - Defense World
XTX Topco Ltd Invests $2.49 Million in Mettler-Toledo International Inc. (NYSE:MTD) - Defense World
Inspire Investing LLC Sells 357 Shares of Mettler-Toledo International Inc. (NYSE:MTD) - Defense World
Mettler-Toledo International Inc. (NYSE:MTD) Shares Acquired by Meiji Yasuda Life Insurance Co - Defense World
Mettler-Toledo International Inc. (NYSE:MTD) Shares Purchased by Dai ichi Life Insurance Company Ltd - Defense World
Federated Hermes Inc. Has $10.72 Million Holdings in Mettler-Toledo International Inc. (NYSE:MTD) - Defense World
āshibio Announces Appointment of Dipal Doshi, CEO of Entrada Therapeutics, to its Board of Directors - Business Wire
Quest Partners LLC Has $147,000 Stake in Mettler-Toledo International Inc. (NYSE:MTD) - Defense World
Entrada Therapeutics Inc Stock (TRDA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.75%
0.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):